World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 12 December 2020
Main ID:  NCT02400047
Date of registration: 23/03/2015
Prospective Registration: Yes
Primary sponsor: Rennes University Hospital
Public title: Dexamethasone, Can it Replace Ketoprofen in the Strategy of Intraoperative Multimodal Analgesia in Paediatric Surgery ? A Prospective Randomized Double-blinded Study. DEXA OP DEXA OP
Scientific title: Dexamethasone, Can it Replace Ketoprofen in the Strategy of Intraoperative Multimodal Analgesia in Paediatric Surgery ? A Prospective Randomized Double-blinded Study. DEXA OP
Date of first enrolment: June 3, 2015
Target sample size: 580
Recruitment status: Completed
URL:  https://clinicaltrials.gov/show/NCT02400047
Study type:  Interventional
Study design:  Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Double (Participant, Investigator).  
Phase:  Phase 3
Countries of recruitment
France
Contacts
Key inclusion & exclusion criteria

Inclusion Criteria:

- Children, aged 1 to 16 years

- Undergoing surgery (orchiopexy, inguinal hernia, circumcision, adenoidectomy,
tonsillectomy or orthopedic act with osteosynthesis)

- Parental consent

Exclusion Criteria:

- Contraindication to NSAI or DXM

- Hypersensitivity to ketoprofen, DXM, hypnovel or atarax

- Porphyria

- Long QT Syndrome

- Renal or hepatic impairment

- Corticosteroid consumption the week before surgery

- NSAI consumption within 48 hours before surgery

- IV induction for full stomach or myopathic patient.

- French language not spoken by parents.

- Simultaneous participation in biomedical research on health products



Age minimum: 1 Year
Age maximum: 16 Years
Gender: All
Health Condition(s) or Problem(s) studied
Postoperative Nausea and Vomiting
Intervention(s)
Drug: Dexamethasone 0.2 mg/kg
Drug: Ketoprofen 1 mg/kg
Drug: Dexamethasone 0.4 mg/kg
Primary Outcome(s)
Maximum intensity of postoperative pain [Time Frame: 1 hour]
Secondary Outcome(s)
Length of stay [Time Frame: 24 hours]
Parent's satisfaction [Time Frame: 24 hours]
Rescue analgesic consumption [Time Frame: 24 hours]
Side effects [Time Frame: 24 hours]
Intensity of postoperative pain [Time Frame: 24 hours]
Pediatric Anesthesia Emergence Delirium Scale (PAEDS) [Time Frame: 24 hours]
Secondary ID(s)
35RC14_9853_DEXA OP
141557A-32
2014-005026-35
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history